Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Increase (Decrease) in Due to Related Parties

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Increase (Decrease) in Due to Related Parties

Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Due to Related Parties of -$27.64 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2019-12-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2019-12-16

  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2018-09-30 was $0.00.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2018-06-30 was $0.00.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2018-03-31 was -$17.64K.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for the quarter ending 2017-12-31 was -$10.00K.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2018 was -$27.64K.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2016 was -$42.75K, a 399.95% decline from fiscal 2015.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2015 was $14.25K, a 4971.89% increase from fiscal 2014.
  • Citius Pharmaceuticals, Inc. increase (decrease) in due to related parties for fiscal 2014 was $281.00.
Period endIncrease (Decrease) in Due to Related Parties 3 monthIncrease (Decrease) in Due to Related Parties 6 monthIncrease (Decrease) in Due to Related Parties 9 monthIncrease (Decrease) in Due to Related Parties 12 month
2018-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16
$0.00
derived: sum of 2 quarters · filed 2019-12-16
-$17.64K
derived: sum of 3 quarters · filed 2019-12-16
-$27.64K
10-K · filed 2019-12-16
2018-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14
-$17.64K
derived: sum of 2 quarters · filed 2019-08-14
-$27.64K
10-Q · filed 2019-08-14
2018-03-31-$17.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15
-$27.64K
10-Q · filed 2019-05-15
2017-12-31-$10.00K
10-Q · filed 2019-02-14
2016-09-30-$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11
-$40.97K
derived: sum of 2 quarters · filed 2018-12-11
-$42.75K
10-K · filed 2018-12-11
2016-06-30-$30.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14
-$32.75K
10-Q · filed 2017-08-14
2016-03-31-$1.77K
10-Q · filed 2017-05-15
2015-09-30$5.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13
-$16.56K
derived: sum of 2 quarters · filed 2017-12-13
$14.25K
10-K · filed 2017-12-13
2015-06-30-$21.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15
$8.95K
10-Q · filed 2016-08-15
2015-03-31$30.81K
10-Q · filed 2015-05-13
2014-09-30-$701.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23
-$420.00
derived: sum of 2 quarters · filed 2016-12-23
$281.00
10-K · filed 2015-12-14
$281.00
10-K · filed 2016-12-23
2014-06-30$281.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-13
$281.00
derived: sum of 2 quarters · filed 2015-08-13
$982.00
10-Q · filed 2015-08-13
2014-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-13
$701.00
10-Q · filed 2015-05-13
2013-12-31$701.00
10-Q · filed 2015-02-17
$18.31K
10-K · filed 2015-12-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36